Pulse Therapeutics, Inc.
Magnetic particle technology to deliver thrombolytic agents to distal emboli in acute ischemic stroke
- Sector
- Medtech
- Headquarters
- Saint Louis, MO
- Founded
- 2008
- Latest Form D
- $5.6M, Jan 2016
- Total capital
- $17.3M
- Federal grants
- $6.2M
- 7 awards · 2015–2022
- Rank in peer group#109 of 538
- Private capital raised
- $11.1M
- 4 Form D · last Jan 2016
- 129 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 13
- 13 pending · first 2015
- Rank in peer group#49 of 538
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Magnetically Enhanced Diffusion for Intra-Arterial Treatment of Acute Ischemic Stroke$1.1M
- Federal grantHealth and Human S · Phase II · Magnetically Enhanced Diffusion for Intra-Arterial Treatment of Acute Ischemic Stroke$2.1M
- Federal grantHealth and Human S · Phase I · Magnetic Targeting and Dose Reduction of Tenecteplase in the Treatment of STEMI for Underserved Populations$289K
- Federal grantHealth and Human S · Phase II · Magnetically Enhanced Diffusion for Intra-Arterial Treatment of Acute Ischemic Stroke$367K
- Federal grantHealth and Human S · Phase II · Rapid Magnetomotive Thrombolysis for Stroke$748K
- Private capital raisedForm D · SEC · 4th filing$5.6M
- Federal grantHealth and Human S · Phase II · Rapid Magnetomotive Thrombolysis for Stroke$1.5M
- Private capital raisedForm D · SEC · 3rd filing$1M
- Private capital raisedForm D · SEC · 2nd filing$3.1M
- Private capital raisedForm D · SEC · 1st filing$1.3M
Show 1 earlier federal award
- Federal grantHealth and Human S · Phase I · Rapid STEMI Fibrinolysis for Underserved Populations$198K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grants#109 · top 20%
- Granted patents#49 · top 9%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Francis M. CreightonResearcherExecutive Officer, DirectorLinked by 11 patents · $1.5M in grants as PI
- SEAN MORRISResearcherExecutive Officer, DirectorLinked by 1 patent
- Amy L. BoyetExecutive OfficerNamed in SEC Form D filings
- Bevil J. HoggDirectorNamed in SEC Form D filings
- Daniel J. BroderickDirectorNamed in SEC Form D filings
- Eric A. GulveDirectorNamed in SEC Form D filings
Show all 13 people
- ERIC MOESSINGERDirectorNamed in SEC Form D filings
- James C. WachtmanExecutive OfficerNamed in SEC Form D filings
- Peggy A. StohrExecutive OfficerNamed in SEC Form D filings
- Peter S. FinleyExecutive OfficerNamed in SEC Form D filings
- Rogers A. RitterExecutive OfficerNamed in SEC Form D filings
- Stephen A. WexlerDirectorNamed in SEC Form D filings
- Thomas J. HillmanDirectorNamed in SEC Form D filings
What it has protected
USPTO · 13 granted of 26- PendingMagnetically Controlled Flow GenerationUSPTOApplication 18971915
- GrantedMagnetic Particle Control And VisualizationUSPTOUS 12,370,259
- PendingDelivery Of Magnetic Particles In Conjunction With Therapeutic And/or Diagnostic AgentsUSPTOApplication 18593397
Show all 26 patent records
- Magnetically Controlled Flow GenerationOct 30, 2025 · Application 18971915Pending
- Magnetic Particle Control And VisualizationJul 29, 2025 · US 12,370,259Granted
- Delivery Of Magnetic Particles In Conjunction With Therapeutic And/or Diagnostic AgentsJan 16, 2025 · Application 18593397Pending
- Magnetic-based Systems And Methods For Manipulation Of Magnetic ParticlesDec 26, 2024 · Application 18510188Pending
- Magnetically Controlled Flow GenerationDec 24, 2024 · US 12,171,443Granted
- Devices For Controlling Magnetic Nanoparticles To Treat Fluid ObstructionsOct 31, 2024 · Application 18519442Pending
- Determination Of Structure And Traversal Of Occlusions Using Magnetic ParticlesMar 5, 2024 · US 11,918,315Granted
- Magnetic Particle Control And VisualizationMar 28, 2023 · US 11,612,655Granted
- Devices For Controlling Magnetic Nanoparticles To Treat Fluid ObstructionsSep 16, 2021 · Application 17079776Pending
- Magnetic Particle Control And VisualizationMay 11, 2021 · US 11,000,589Granted
- Iron Oxide Magnetic Particle Compositions And Methods Of Synthesizing SameApr 1, 2021 · Application 16871403Pending
- Delivery Of Magnetic Particles In Conjunction With Therapeutic And/or Diagnostic AgentsNov 19, 2020 · Application 16766906Pending
- Devices For Controlling Magnetic Nanoparticles To Treat Fluid ObstructionsOct 27, 2020 · US 10,813,997Granted
- Detection Of Fluidic Current Generated By Rotating Magnetic ParticlesMay 12, 2020 · US 10,646,241Granted
- Magnetic Particle Control And VisualizationDec 25, 2018 · US 10,159,734Granted
- Therapeutic Magnetic Control Systems And Contrast AgentsJul 24, 2018 · US 10,029,008Granted
- Magnetic-based Systems And Methods For Manipulation Of Magnetic ParticlesFeb 6, 2018 · US 9,883,878Granted
- Methods Of Controlling Magnetic Nanoparticles To Improve Vascular FlowMay 24, 2016 · US 9,345,498Granted
- Control Of Magnetic Rotors To Treat Therapeutic TargetsMay 17, 2016 · US 9,339,664Granted
- Controlling Magnetic Nanoparticles To Increase Vascular FlowJan 6, 2015 · US 8,926,491Granted
- Delivery Of Magnetic Particles In Conjunction With Therapeutic And/or Diagnostic AgentsApplication PCTUS2018062610Pending
- Magnetomotive Stator System And Methods For Wireless Control Of Magnetic RotorsApplication PCTUS2010055133Pending
- Determination Of Clot Morphology And Structure Using Magnetic ParticlesApplication 62666639Pending
- Magnetic Particle Control And VisualizationApplication 18189058Pending
- Magnetically Controlled Flow GenerationApplication 63200476Pending
- Magnetic-based Systems And Methods For Manipulation Of Magnetic ParticlesApplication PCTUS2013040789Pending
Related companies, and why
- UNANDUP, LLCSimilar federal contract value in Medtech · null in contracts
- INTUOR TECHNOLOGIES LLCSimilar federal contract value in Medtech · null in contracts
- LASE INNOVATION INCSimilar federal contract value in Medtech · null in contracts
- ASSIST EQUIPMENT DEVELOPMENT, INC.Similar federal contract value in Medtech · null in contracts
- PROPEL ORTHODONTICS, LLCSimilar federal contract value in Medtech · null in contracts
- GUANINE, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .